Keyphrases
Osteopontin
100%
Breast Cancer Patients
100%
Taxanes
100%
Neuropathy
100%
Nerve Conduction
100%
Nerve Conduction Studies
50%
Chemotherapy
33%
Novel Biomarkers
16%
Sural
16%
Sural Nerve
16%
Action Potential
16%
Detrimental Effects
16%
Peroneal
16%
Quality of Life Questionnaire
16%
Quality of Life
16%
Lower Limb
16%
Patient Well-being
16%
Clinical Examination
16%
Poor Outcome
16%
Docetaxel
16%
Paclitaxel
16%
Specific Treatment
16%
Women with Breast Cancer
16%
Neuropathic Pain
16%
Low Serum
16%
Patient Subgroups
16%
Chemotherapy-induced Peripheral Neuropathy
16%
Axonal Loss
16%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Osteopontin
100%
Neuropathy
100%
Taxane
100%
Chemotherapy
33%
Ethambutol
33%
Biological Marker
16%
Prospective Study
16%
Paclitaxel
16%
Docetaxel
16%
Chemotherapy-Induced Peripheral Neuropathy
16%
Neuroscience
Osteopontin
100%
Nerve Conduction
100%
Taxane
100%
Neuropathy
100%
Nerve Conduction Study
50%
Sural Nerve
16%
Action Potential
16%
Paclitaxel
16%
Docetaxel
16%
Biochemistry, Genetics and Molecular Biology
Nerve Conduction
100%
Osteopontin
100%
Nerve Conduction Study
50%
Action Potential
16%
Prospective Study
16%